
ANGO
AngioDynamics Inc.
$10.73
-$0.04(-0.37%)
42
Overall
60
Value
25
Tech
--
Quality
Market Cap
$437.63M
Volume
287.24K
52W Range
$5.83 - $13.50
Target Price
$19.00
Order:
Income Statement
Metric | Trend | Chart | 2016 May | 2017 May | 2018 May | 2019 May | 2020 May | 2021 May | 2022 May | 2023 May | 2024 May | 2025 May |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $353.9M | $349.6M | $261.7M | $270.6M | $264.2M | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M | ||
Total Revenue | $353.9M | $269.8M | $261.7M | $270.6M | $264.2M | $291.0M | $316.2M | $338.8M | $303.9M | $292.5M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-179.6M | $-173.5M | $-117.8M | $114.6M | $113.9M | $134.2M | $150.5M | $164.5M | $149.2M | $134.8M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $174.3M | $143.9M | $143.9M | $156.0M | $150.3M | $156.8M | $165.7M | $174.2M | $154.7M | $157.7M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-173.3M | $-163.2M | $-158.0M | $165.4M | $317.4M | $192.1M | $183.9M | $225.4M | $401.6M | $197.7M | ||
Research & Development | $25.1M | $25.3M | $24.3M | $28.3M | $29.7M | $36.4M | $30.7M | $29.9M | $31.5M | $26.2M | ||
Research Expense | $25.1M | $25.3M | $24.3M | $28.3M | $29.7M | $36.4M | $30.7M | $29.9M | $31.5M | $26.2M | ||
Selling, General & Administrative | $114.3M | $110.2M | $104.1M | $111.7M | $116.5M | $117.2M | $133.8M | $144.3M | $144.0M | $145.2M | ||
Selling & Marketing Expenses | $83.7M | $78.8M | $73.1M | $76.8M | $78.6M | $81.3M | $95.3M | $104.2M | $102.8M | $103.1M | ||
General & Administrative Expenses | $30.6M | $31.4M | $31.0M | $34.9M | $37.9M | $35.9M | $38.5M | $40.0M | $41.2M | $42.1M | ||
Salaries & Wages | $-3.2M | $-6.2M | $-7.9M | $-2.1M | $-1.7M | $-2.0M | $-2.5M | -- | -- | -- | ||
Depreciation & Amortization | $18.0M | $17.3M | $13.9M | $17.1M | $18.1M | $18.1M | $19.5M | $18.8M | $13.0M | $10.3M | ||
Depreciation & Amortization | $18.0M | $17.3M | $13.9M | $17.1M | $18.1M | $18.1M | $19.5M | $18.8M | $13.0M | $10.3M | ||
Amortization | $18.0M | $17.3M | $13.9M | $17.1M | $18.1M | $18.1M | $19.5M | $18.8M | $13.0M | $10.3M | ||
Other Operating Expenses | $16.0M | $10.4M | $15.7M | $-8.4M | $5.5M | $-20.3M | $2.8M | -- | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $1.0M | $13.0M | $-14.2M | $-9.4M | $-167.1M | $-35.3M | $-28.5M | $-51.2M | $-192.4M | $-40.0M | ||
EBITDA | $28.2M | $37.5M | $9.0M | $16.3M | $-143.4M | $-9.3M | $88.0K | $-20.9M | $-165.5M | $-9.2M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $3.4M | $2.8M | $3.1M | $5.1M | $907.0K | $861.0K | $688.0K | $2.7M | $-1.6M | $-978.0K | ||
Intinc | $11.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-3.4M | $-2.8M | $-3.1M | $-5.1M | $-907.0K | $-861.0K | $-688.0K | $-2.7M | $1.6M | $978.0K | ||
Other Income/Expense | $886.0K | $-9.6M | $17.3M | $14.9M | $130.0K | $-92.0K | $-11.0M | $554.0K | $-53.7M | $-4.9M | ||
Other Special Charges | $-886.0K | $9.6M | $-31.0K | $-14.9M | $-130.0K | $92.0K | $-790.0K | $-554.0K | $-817.0K | $4.9M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | $-1.3M | $-4.7M | $288.0K | $26.0K | -- | -- | -- | -- | -- | ||
Special Income Charges | -- | $1.3M | $4.7M | $-288.0K | $-158.6M | -- | -- | $-14.5M | $-159.5M | -- | ||
Impairment of Capital Assets | -- | -- | -- | -- | $158.6M | -- | -- | $14.5M | $159.5M | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $132.0K | $12.7M | $-14.2M | $-9.6M | $-167.2M | $-35.2M | $-29.3M | $-51.7M | $-193.3M | $-35.0M | ||
Pre-Tax Income | $-3.3M | $9.8M | $-17.3M | $-14.7M | $-168.1M | $-36.1M | $-29.9M | $-54.4M | $-191.6M | $-34.0M | ||
INCOME TAX | ||||||||||||
Tax Provision | $40.3M | $4.8M | $-11.0M | $-3.6M | $-1.3M | $-4.5M | $-3.4M | $-2.0M | $-7.3M | $-39.0K | ||
NET INCOME | ||||||||||||
Net Income | $-46.8M | $14.9M | $-23.5M | $61.3M | $-166.8M | $-31.5M | $-26.5M | $-52.4M | $-184.3M | $-34.0M | ||
Net Income (Continuing Operations) | $-46.8M | $14.9M | $-23.5M | $61.3M | $-166.8M | $-31.5M | $-26.5M | $-52.4M | $-184.3M | $-34.0M | ||
Net Income (Discontinued Operations) | $-46.8M | $14.9M | $-23.5M | $61.3M | $-166.8M | $-31.5M | $-26.5M | $-52.4M | $-184.3M | $-34.0M | ||
Net Income (Common Stockholders) | $-46.8M | $14.9M | $-23.5M | $-9.2M | $-166.8M | $-31.5M | $-26.5M | $-52.4M | $-184.3M | $-34.0M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-34.1M | ||
TOTALS | ||||||||||||
Total Expenses | $-352.9M | $-336.7M | $-275.8M | $280.0M | $431.3M | $326.3M | $334.4M | $389.9M | $550.8M | $332.5M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $36.2M | $36.6M | $37.1M | $37.5M | $38.0M | $38.3M | $39.0M | $39.5M | $40.2M | $40.9M | ||
Average Shares Outstanding (Diluted) | $36.2M | $37.0M | $37.1M | $37.5M | $38.0M | $38.3M | $39.0M | $39.5M | $40.2M | $40.9M | ||
Shares Outstanding | $36.4M | $36.6M | $36.9M | $37.3M | $37.9M | $38.4M | $39.0M | $39.7M | $40.3M | $40.6M | ||
Basic EPS | $-1.21 | $0.14 | $0.44 | $1.63 | $-4.39 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | ||
Basic EPS (Continuing Operations) | -- | -- | $-0.17 | $-0.30 | $-4.39 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | ||
Diluted EPS | $-1.21 | $0.14 | $0.44 | $1.63 | $-4.39 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-0.17 | $-0.30 | $-4.39 | $-0.82 | $-0.68 | $-1.33 | $-4.59 | $-0.83 | ||
OTHER METRICS | ||||||||||||
Acquired In Process Rn D | -- | $9.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
Basic Discontinuous Operations | -- | -- | $0.61 | $1.93 | -- | -- | -- | -- | -- | -- | ||
Diluted Discontinuous Operations | -- | -- | $0.61 | $1.93 | -- | -- | -- | -- | -- | -- | ||
Earnings from equity interest | -- | -- | -- | -- | -- | $-36.1M | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | $-36.1M | -- | -- | -- | -- | ||
Gain On Sale Of P P E | -- | -- | -- | -- | $-168.1M | -- | -- | -- | $54.5M | -- | ||
Net Income Discontinuous Operations | -- | -- | $22.6M | $72.5M | -- | -- | -- | -- | -- | -- | ||
Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | $72.5M | -- | -- | -- | -- | -- | -- | ||
Other Gand A | $30.6M | $31.4M | $31.0M | $34.9M | $37.9M | $35.9M | $38.5M | $40.0M | $41.2M | $42.1M | ||
Other Impairment Of Capital Assets | $-100.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Realized Capital Gain | -- | -- | $7.5M | -- | -- | -- | -- | -- | -- | -- | ||
Rent And Landing Fees | $30.6M | $31.4M | $31.0M | $2.5M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | $83.7M | $78.8M | $73.1M | -- | -- | -- | -- | -- | -- | -- | ||
Restruct | -- | $-1.3M | $-4.7M | $288.0K | $26.0K | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ANGO | $10.73 | -0.4% | 287.24K |
3 | ||||
4 | ||||
5 | ||||
6 |